Partner and Vice President-Chemistry, Emmyon, Inc.
Dr. John Talley, Chief Science Officer for Euclises Pharmaceuticals and SARmont, brings over thirty years experience and a record as one of the world’s most successful medicinal chemists. He is best known as the co-inventor of the blockbuster COX-2 inhibitor celecoxib (Celebrex®) and follow-on coxibs Bextra® and Dynastat®. In addition, John played a major role in the discovery of the HIV protease inhibitors Agenerase®, Lexiva®, and Prezista®. In all, he is a co-inventor of seven marketed drugs, with several more still in development. He previously served as Senior Vice President at Ironwood Pharmaceuticals and in various roles at G. D. Searle and Pharmacia. He is a named inventor on more than 215 issued U.S. drug patents, authored over 50 peer reviewed publications, and has been honored with the prestigious PhRMA Discoverers Award in 2002.